The third international stroke trial (IST-3) of thrombolysis for acute ischaemic stroke

<p>Abstract</p> <p>Background</p> <p>Intravenous recombinant tissue plasminogen activator (rt-PA) is approved for use in selected patients with ischaemic stroke within 3 hours of symptom onset. IST-3 seeks to determine whether a wider range of patients may benefit.</...

Full description

Bibliographic Details
Main Authors: Cantisani Teresa, Righetti Enrico, Celani Maria, Ricci Stefano, Brainin Michael, Matz Karl, Hankey Graeme, Peeters Andre, Murray Veronica, Slot Karsten, Berge Eivind, Czlonkowska Anna, Kobayashi Adam, Venables Graham, Lewis Steff, Dennis Martin, Wardlaw Joanna, Lindley Richard, Sandercock Peter, Gubitz Gord, Phillips Steve, Arauz Antonio, Prasad Kameshwar, Correia Manuel, Lyrer Phillippe
Format: Article
Language:English
Published: BMC 2008-06-01
Series:Trials
Online Access:http://www.trialsjournal.com/content/9/1/37